UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Antibody-directed enzyme prodrug therapy: Pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial

Martin, J; Stribbling, SM; Poon, GK; Begent, RHJ; Napier, M; Sharma, SK; Springer, CJ; (1997) Antibody-directed enzyme prodrug therapy: Pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 40 (3) pp. 189-201. 10.1007/s002800050646.

Full text not available from this repository.
Type: Article
Title: Antibody-directed enzyme prodrug therapy: Pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial
DOI: 10.1007/s002800050646
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology, Pharmacology & Pharmacy, ADEPT, prodrug, carboxypeptidase G2, ALKYLATING-AGENTS, CARBOXYPEPTIDASE-G2, SITES, MICE
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/1518590
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item